Colgate-Palmolive Company (CL)
NYSE · New York, New York, USA · Founded 1806 · CEO Noel Wallace
Valuation summary
$60.29 fair value versus $96.88 in the market, a difference of -37.8%. Rated Sell.
| Fair value per share | $60.29 |
| Current share price | $96.88 |
| Upside / downside | -37.8% |
| Bear case | $33.25 |
| Bull case | $101.64 |
| Discount rate (WACC) | 7.9% |
| Terminal growth | 2.40% |
| Market capitalisation | $77B |
| EV / Sales | 4.0x |
About Colgate-Palmolive Company
Founded in 1806 by William Colgate as a soap and candle business in New York. Noel Wallace has been CEO since 2019. Colgate sells toothpaste, toothbrushes, soap and home care products, and owns Hill's Pet Nutrition, a premium veterinary-recommended pet food business that has become the growth engine. Colgate toothpaste holds roughly 40% global market share, an extraordinary position for a consumer category.
Investment case
- Around 40% global toothpaste share, with particular strength in emerging markets.
- Hill's Pet Nutrition benefits from the same pet humanisation trend as Zoetis, with better growth than the core business.
- Oral care is a daily habit purchase, about as recession-resistant as consumer spending gets.
Key risks
- Heavy emerging market exposure creates significant currency translation risk.
- Private label competition in developed markets pressures volumes.
- Growth has come more from price than volume, which is not indefinitely sustainable.
Recent developments
- 2026-10-30 · Q3 sales up 4.6% to $5.37bn with organic growth accelerating to 1.8% and Hill's up 6.5%; gross margin guidance raised source
- 2026-09-17 · Colgate-Palmolive declared a regular quarterly dividend of $0.53 per share source
- 2026-09-04 · S&P Dow Jones Indices said Colgate-Palmolive would leave the S&P 100 in the 21 September 2026 rebalance source
Revenue by segment
| Oral Care | 40% |
| Personal Care | 18% |
| Home Care | 19% |
| Hill's Pet Nutrition | 23% |
Five-year forecast
| Revenue | Free cash flow | |
|---|---|---|
| Year 1 | $22.4B | $2.4B |
| Year 2 | $23.7B | $2.5B |
| Year 3 | $25.1B | $2.7B |
| Year 4 | $26.6B | $2.9B |
| Year 5 | $28.2B | $3.1B |
What the street says
A defensive staple where the debate is whether Hill's growth can offset a slow-growing core.
Comparable companies: MAR · HLT · MDLZ · EL · ORLY · AZO · TGT · PEP
Open the interactive model, price chart and sensitivity grid →